U.S. District Judges Brian R. Martinotti of the District of New Jersey, left, and Wendy Beetlestone, right, of the Eastern District of Pennsylvania (Courtesy photos)
Lawyers from several prominent firms are gearing up for a fight over which judge should oversee potentially hundreds of lawsuits filed over the pharmaceutical drug Elmiron.
About 80 lawsuits allege that Elmiron, used to treat a chronic bladder infection called interstitial cystitis, causes eye problems. Most cases are in either Pennsylvania or New Jersey, the headquarters of defendant Janssen Pharmaceuticals and its parent corporation, Johnson & Johnson.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
